The most bioavailable supplemental choline source for the brain, delivering acetylcholine precursor directly across the blood-brain barrier.
40%
Choline by Weight
1,200mg
Optimal Daily Dose
257.22
Molecular Weight
Clinical Research
8+ Studies Reviewed
Your complete visual guide to understanding Alpha-GPC's mechanisms, benefits, and protocols
Choline Content (highest of any choline compound)
MCI Patient Response Rate (1,200mg/day)
Standard Single Dose ( athletes)
Time to Peak Plasma Concentration
Result: Enhanced cognitive function, memory consolidation, and focus
| Parameter | Alpha-GPC | CDP-Choline | Choline Bitartrate |
|---|---|---|---|
| Choline Content | 40% | 18% | 41% |
| BBB Penetration | Excellent | Good | Poor |
| Cognitive Effects | Strong | Moderate | Weak |
| Free Choline Release | Highest | Moderate | Low |
| Primary Use | Nootropic | Cytidine Source | Liver Support |
Key Takeaway: Alpha-GPC delivers the most free choline to the brain, making it the superior choice for cognitive enhancement.
Morning (6-8 AM)
Best for cognitive enhancement - takes 1-3 hours to peak
Pre-Workout (30-60 min before)
Athletic performance - 30 min before training
Avoid Evening Doses
May interfere with sleep due to acetylcholine activity
Focus Stack
Alpha-GPC 300mg + Caffeine 100mg + L-Theanine 200mg
Memory Stack
Alpha-GPC 300mg + Bacopa Monnieri 300mg + Lion's Mane 1g
Pre-Workout Stack
Alpha-GPC 300mg + Creatine 5g + Beta-Alanine 3g
Neuroprotective Stack
Alpha-GPC 300mg + DHA 1g + Alpha Lipoic Acid 600mg
Clinical trials consistently show benefits for age-related cognitive decline at 1,200 mg/day, while smaller studies suggest acute gains in focus and power output among healthy adults. However, emerging research on the TMAO metabolic pathway has raised cardiovascular questions that remain unresolved, making an evidence-based, safety-first approach essential for anyone considering this compound.
Alpha-GPC (L-alpha glycerylphosphorylcholine) occurs naturally in the brain as an intermediate metabolite of phosphatidylcholine. It is sold as a dietary supplement in the UK and US, while several EU member states (notably Italy) classify it as a prescription pharmaceutical. Its molecular formula is C₈H₂₀NO₆P, with a molecular weight of 257.22 g/mol and approximately 40% choline by weight — the highest concentration among supplemental choline forms.
Developed by
Zenith Labs
By Dr. Ryan Shelton, Zenith Labs
Brain C-13 targets neurotransmitter optimisation through Huperzine-A and Phosphatidylserine. This comprehensive formula supports acetylcholine production for sharper memory recall, while Bacopa and Rhodiola combat mental fatigue and stress.
After oral ingestion, Alpha-GPC follows a dual-action pathway that distinguishes it from simpler choline salts. The compound is hydrolysed in the gut into two components:
Crosses the blood-brain barrier efficiently. A 1,000 mg dose raises plasma choline by 49% within 60 minutes.
Recombines with fatty acids to rebuild phosphatidylcholine in neuronal membranes.
Acetylcholine Synthesis
Via choline acetyltransferase
The strongest human evidence exists for cognitive decline populations, with promising findings for mild cognitive impairment.
+3.2
points improvement in Alzheimer's patients (Moreno 2003)
46%
vs 10% on placebo in 261 patients over 180 days
-10%
lower risk of progression (Kim 2025, n=508,107)
De Jesus Moreno (2003)
RCT, 261 patients, mild-to-moderate Alzheimer's, 1,200 mg/day × 180 days
ASCOMALVA Trial (2012–2017)
113 Alzheimer's patients, Alpha-GPC + donepezil vs donepezil alone, 24 months
Sagaro Meta-analysis (2023)
8 studies, 861 participants, significant benefits for cognition and behaviour
Kim et al. (2025)
508,107 MCI patients, 10% lower Alzheimer's risk, 17% lower vascular dementia risk
Ziegenfuss et al. (2008)
600 mg pre-exercise: 44-fold peak GH increase, 14% greater bench press force
Bellar & LeBlanc (2015)
600 mg/day × 6 days: 3% increase in lower-body isometric strength
Kerksick et al. (2024)
630 mg acutely: Improved Stroop test, no physical performance enhancement
Note: Athletic studies have small sample sizes; some with industry funding.
Evidence-based dosing recommendations from clinical trials
| Purpose | Dose | Timing | Duration Studied |
|---|---|---|---|
|
|
300–600 mg/day | Morning or early afternoon | Ongoing (limited long-term data) |
|
|
600 mg/day | Split or single dose | 12 weeks (Jeon 2024) |
|
|
1,200 mg/day (3 × 400 mg) | Divided throughout day | Up to 6 months (Moreno 2003) |
|
|
300–600 mg | 60–90 minutes pre-exercise | Acute to 7 days |
The most significant safety concern involves the trimethylamine N-oxide (TMAO) pathway. Gut microbiota convert choline released from Alpha-GPC into trimethylamine (TMA), which hepatic FMO3 enzymes then oxidise to TMAO — a metabolite associated with atherosclerotic cardiovascular disease in observational studies.
2021 Korean Cohort Study (Lee et al.)
Over 12 million adults: Alpha-GPC users had a 46% higher 10-year stroke risk
Confounders: users were older, sicker, prescribed Alpha-GPC for pre-existing conditions
2025 Kim et al. Study
Same Korean database, MCI patients: Reduced stroke risk among those who did not progress to dementia
Conflicting findings highlight the complexity of this relationship
December 2024 (Yanaka et al.)
Identified intestinal enzyme Gpcpd1 as key mediator of TMAO production — individual variation may explain differing cardiovascular responses
No regulatory body has issued formal safety warnings for Alpha-GPC
No RCT has directly tested whether Alpha-GPC causes cardiovascular events
Individuals with cardiovascular risk factors should exercise caution
Long-term use exceeding 6 months warrants extra scrutiny
In clinical trials at 1,200 mg/day, approximately 8% of patients experienced:
Contraindicated: Anticholinergic medications (e.g., scopolamine). Caution with acetylcholinesterase inhibitors without medical supervision.
Key facts and mechanisms in an easy-to-understand visual format
C₈H₂₀NO₆P
257.22 g/mol
40%
Highest among supplements
1–3 hrs
Plasma peak at 60 min
Efficient
Direct precursor delivery
Ingestion
Alpha-GPC
Gut
Hydrolysis
Component 1
Free Choline
Component 2
Glycerophosphate
BBB → Brain
Acetylcholine
Neuronal
Membrane Repair
Understanding the differences between choline forms helps you make informed supplementation choices
| Parameter | Alpha-GPC | CDP-Choline | Choline Bitartrate | Phosphatidylcholine |
|---|---|---|---|---|
| Choline by Weight | ~40% | ~18% | ~41% | ~13% |
| Crosses BBB | Efficiently | Yes (reformed) | Poorly | Via lipoproteins |
| Typical Daily Dose | 300–1,200 mg | 250–2,000 mg | 500–2,000 mg | 420–840 mg |
| Onset | Fast (1–3 hrs) | Moderate (biphasic) | Fast systemically | Slow |
| Best Suited For | Acute cognition, athletics | Long-term brain health | Dietary adequacy | General health |
| Long-term Safety | TMAO concerns | Well established | Established | Well established |
Despite similar choline content by weight, choline bitartrate crosses the blood-brain barrier poorly and is largely ineffective for cognitive applications. CDP-choline may be preferable for long-term daily use due to its additional uridine pathway benefits and stronger safety profile. A 2025 meta-analysis (Sagaro & Amenta, Frontiers in Neurology) found Alpha-GPC outperformed citicoline on cognitive scales in head-to-head dementia trials.
Evidence-based combinations to enhance cognitive effects
Alpha-GPC is most commonly paired with racetams (piracetam, aniracetam) because these compounds increase acetylcholine turnover, depleting choline reserves. This combination prevents the "racetam headache."
Works with: Piracetam, Aniracetam, Oxiracetam, Pramiracetam
For calm, focused energy without stimulants, combine Alpha-GPC with caffeine and L-theanine for complementary effects.
Combining Alpha-GPC with Lion's Mane mushroom targets both acetylcholine and NGF (nerve growth factor) pathways simultaneously.
Dual action: Acetylcholine + NGF pathways
Reduce dose if you experience:
Cycling protocols (5 days on, 2 off) are commonly recommended, though no clinical data validates this practice.
Alpha-GPC's position in the nootropics landscape is defined by a genuine tension: strengthening cognitive evidence against a backdrop of unresolved cardiovascular questions.
The 2024–2025 research wave — large cohort studies, new RCTs, supportive meta-analyses — makes a credible case for benefit under medical guidance.
The evidence is thinner, limited to small acute studies. The prudent approach is to use the minimum effective dose (300–600 mg).
Use the minimum effective dose
300–600 mg is sufficient for most cognitive applications
Avoid indefinite continuous supplementation
Consider cycling or periodic breaks, especially beyond 6 months
Consider CDP-choline for long-term daily use
Stronger safety profile with additional neuroprotective benefits
Consult a healthcare professional
Essential if you have cardiovascular risk factors before supplementing
Monitor emerging TMAO research
The science continues to evolve; stay informed about new findings
Last updated: April 2026 | Based on published clinical research through Q1 2026
Explore evidence-based nootropic combinations designed to work synergistically with Alpha-GPC for enhanced focus, memory, and mental performance.
Medical Disclaimer: The information provided on this website is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any supplementation regimen. Individual responses to supplements may vary.
© 2026 Herbal Nootropics. All rights reserved. | Privacy Policy | Terms of Service
